Table 2.
Adjusted hazard ratio of outcomes within 1 year according to TyG index quartiles
| Prognosis | TyG index | n | Events, n (%) |
Model 1 | P Value | Model 2a | P Value |
|---|---|---|---|---|---|---|---|
| Unadjusted HR (95% CI) | Adjusted HR (95% CI) | ||||||
| Stroke recurrence | Q1 (4.31–5.48) | 298 | 31(10.4) | Reference | Reference | ||
| Q2 (5.48–5.81) | 290 | 37(12.8) | 1.38(0.83–2.29) | 0.21 | 1.33(0.80–2.23) | 0.27 | |
| Q3 (5.81–6.22) | 301 | 53(17.6) | 1.97(1.23–3.16) | 0.005 | 2.04(1.26–3.31) | 0.004 | |
| Q4 (6.22–8.17) | 296 | 51(17.2) | 1.86(1.15–3.00) | 0.01 | 1.86(1.13–3.06) | 0.01 | |
| P for trend | 0.03 | 0.03 | |||||
| Death | Q1 (4.31–5.48) | 306 | 19(6.2) | Reference | Reference | ||
| Q2 (5.48–5.81) | 307 | 34(11.1) | 1.85(1.05–3.24) | 0.03 | 1.94(1.09–3.48) | 0.03 | |
| Q3 (5.81–6.22) | 307 | 23(7.5) | 1.14(0.62–2.10) | 0.69 | 1.56(0.83–2.93) | 0.17 | |
| Q4 (6.22–8.17) | 306 | 38(12.4) | 2.05(1.18–3.56) | 0.01 | 2.91(1.62–5.23) | < 0.001 | |
| P for trend | 0.045 | 0.002 |
Abbreviations: TyG index indicates triglyceride glucose index, HR Hazard ratio
aAdjusted for age, sex, body mass index, smoking status, medical history of hypertension, hyperlipidemia, atrial fibrillation and coronary heart disease, antihypertensive drugs, statins, intravenous alteplase, antiplatelet and anticoagulation during hospitalization, pulmonary infection and urinary infection during hospitalization, NIHSS at admission and TOAST subtypes